Experiences with galanthamine hydrobromide as curare antagonist.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000731:Androstanes / Q000037:antagonists & inhibitors; D001835:Body Weight; D004342:Drug Hypersensitivity; D005260:Female; D005702:Galantamine / Q000494:pharmacology*; D005703:Gallamine Triethiodide / Q000037:antagonists & inhibitors; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors; D010880:Piperidines / Q000037:antagonists & inhibitors; D012472:Salivation / Q000187:drug effects; D013256:Steroids / Q000037:antagonists & inhibitors; D014403:Tubocurarine / Q000037:antagonists & inhibitors; D014717:Vertigo
D000731:Androstanes; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D013256:Steroids; D005702:Galantamine; D005703:Gallamine Triethiodide; D014403:Tubocurarine